Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity.

Wang Y, You S, Su S, Yeon A, Lo EM, Kim S, Mohler JL, Freeman MR, Kim HL

Open source

DOI
10.1158/1078-0432.ccr-21-1535
Published
2022 Jan 15
Container
Clinical cancer research : an official journal of the American Association for Cancer Research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-21-1535,
  title = {Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity.},
  author = {Wang Y and You S and Su S and Yeon A and Lo EM and Kim S and Mohler JL and Freeman MR and Kim HL},
  year = {2022},
  journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
  doi = {10.1158/1078-0432.ccr-21-1535},
  url = {https://doi.org/10.1158/1078-0432.ccr-21-1535}
}

RIS

TY  - JOUR
TI  - Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity.
AU  - Wang Y
AU  - You S
AU  - Su S
AU  - Yeon A
AU  - Lo EM
AU  - Kim S
AU  - Mohler JL
AU  - Freeman MR
AU  - Kim HL
PY  - 2022
JO  - Clinical cancer research : an official journal of the American Association for Cancer Research
DO  - 10.1158/1078-0432.ccr-21-1535
UR  - https://doi.org/10.1158/1078-0432.ccr-21-1535
ER  - 

APA

Y, W., S, Y., S, S., A, Y., EM, L., S, K., JL, M., MR, F., & HL, K. (2022). Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-21-1535

Source records